AAP vs BABA

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak operational and balance sheet performance. Despite a modest dividend yield and a low Price/Sales ratio, the company is unprofitable with negative earnings, deteriorating ROE of -23.87%, and a high debt/equity ratio of 2.58. Earnings volatility is extreme, with recent quarters showing massive misses and a YoY EPS growth distortion due to negative prior-year comparisons. The stock trades below fair value expectations but reflects justified risk discounting given persistent profitability and cash flow challenges.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.